This is in accordance with a previous study that focused on disease outcome, which found that anti-LGI-1 encephalitis patients responded better to treatment and had a relatively better prognosis than anti-NMDAR encephalitis patients (26). This evidence concerns the gene LGI1 and encephalitis.